SIGA Technologies Target of Unusually Large Options Trading (NASDAQ:SIGA)

SIGA Technologies, Inc. (NASDAQ:SIGA) was the target of unusually large options trading activity on Wednesday. Traders purchased 1,200 call options on the company. This is an increase of 1,438% compared to the average daily volume of 78 call options.

Institutional Trading of SIGA Technologies

Institutional investors and hedge funds have recently modified their holdings of the company. Hotchkis & Wiley Capital Management LLC increased its position in SIGA Technologies by 152.6% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock worth $13,827,000 after acquiring an additional 1,237,620 shares during the period. American Century Companies Inc. lifted its stake in shares of SIGA Technologies by 251.2% in the second quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock valued at $6,389,000 after buying an additional 602,091 shares during the period. Foundry Partners LLC acquired a new stake in SIGA Technologies during the third quarter worth about $2,801,000. Denali Advisors LLC acquired a new stake in SIGA Technologies during the second quarter worth about $1,815,000. Finally, Harbor Capital Advisors Inc. bought a new stake in shares of SIGA Technologies in the 3rd quarter worth approximately $1,098,000. 55.40% of the stock is currently owned by institutional investors and hedge funds.

SIGA Technologies Stock Performance

SIGA Technologies stock opened at $7.36 on Friday. The firm has a market cap of $525.50 million, a PE ratio of 6.13 and a beta of 0.89. SIGA Technologies has a twelve month low of $4.26 and a twelve month high of $12.83. The firm’s 50 day moving average price is $6.99 and its two-hundred day moving average price is $7.85.

SIGA Technologies (NASDAQ:SIGA) last posted its earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. The company had revenue of $10.01 million for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. Equities analysts anticipate that SIGA Technologies will post 1.04 EPS for the current fiscal year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.